Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Lifted By $2.2bn Zantac Litigation Deal

Oct 10 2024

• By Andrew McConaghie

New GSK sign — • Source: Shutterstock

Related Content

GSK’s Arexvy Reinforces Its Lead In A Stalling RSV Vaccine Market

Oct 09 2024

Related Companies

GSK plc

Sanofi

Boehringer Ingelheim GmbH

Pfizer Inc.

Johnson & Johnson

Additional Topics

Companies Commercial Legal Issues Litigation Gastrointestinal BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window